ST
TTPH

Spot Trading’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Spot Trading’s Portfolio TTPH Stock Details TTPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-500
Closed -$366K – 4389
2015
Q1 		$366K Buy
+500
New +$376K ﹤0.01% 2357

Other funds holding TTPH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Spot Trading's TTPH Position: Q2 2015 in Review

Spot Trading sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q2 2015, closing a stake of 175 shares — an estimated $129K sold.

Spot Trading first reported a position in TTPH in Q1 2015 and held it in 1 quarter. The position peaked at $129K in Q1 2015. 139 funds tracked by Wall St. Rank hold TTPH as of Q2 2015.

  • Spot Trading reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Spot Trading sold 175 Tetraphase Pharmaceuticals, Inc. shares in Q2 2015, an estimated $129K.
  • Spot Trading first reported a position in Tetraphase Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Spot Trading's Tetraphase Pharmaceuticals, Inc. position peaked at $129K in Q1 2015.
  • 139 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q2 2015.

Based on Spot Trading's 13F filing for Q2 2015, filed 11 Aug 2015.